Skip to main content
logo
TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.380
+0.050 (1.15%)
Jul 29, 2026, 4:00 PM EDT - Market closed

TriSalus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
26934915722382309
Market Cap Growth
55.90%122.70%-29.79%171.26%-73.35%-
Enterprise Value
246.94363.37172.32213.01238.84309.09
Last Close Price
4.386.985.018.4510.039.88

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.997.735.3212.066.64-
PB Ratio
21.00-10.31-6.05-8.25-0.47-18.47
P/TBV Ratio
14.97-----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.508.055.8611.5119.26-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.70-1.02-0.92-0.05-0.010.00
Net Debt / Equity Ratio
-1.70-0.42-0.600.380.0414.94
Net Debt / EBITDA Ratio
0.79-0.55-0.440.190.2182.11
Net Debt / FCF Ratio
1.07-0.76-0.380.200.23143.64
Asset Turnover
0.841.521.210.790.090
Inventory Turnover
1.951.961.241.303.07-
Quick Ratio
5.242.351.331.040.34156.22
Current Ratio
5.782.802.021.420.530.33
Return on Equity (ROE)
-102.70%131.29%113.46%58.37%-165.70%-2.06%
Return on Assets (ROA)
-52.73%-90.89%-148.95%-233.87%-26.75%-1.21%
Return on Invested Capital (ROIC)
-376.87%-143.45%-305.84%---
Return on Capital Employed (ROCE)
-67.52%-143.43%-305.78%24157.40%-30.55%-1.21%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-64.63%-49.61%-169.61%-2934.71%-41.31%97.54%
Total Shareholder Return
-64.63%-49.61%-169.61%-2934.71%-41.31%97.54%
SEC Filings: 10-K · 10-Q